EBR Systems (EBR) AGM 2025 summary

Opening remarks and agenda

• Meeting opened with confirmation of quorum, introduction of board members and key executives, and highlighted major milestones achieved over the past year, including regulatory and commercial progress.

• The agenda included strategic updates, voting on proposals, and Q&A opportunities.

Financial performance review

• 2024 was described as a pivotal year, with focus on commercial preparation and successful FDA approval.

• Annual financial statements for the year ended 31 December 2024 were presented for consideration.

• Completed a US $34.0m / A $50.0m capital raise in September 2024 to support growth and commercialization.

Board and executive committee updates

• Directors and executive team introduced, highlighting their diverse expertise in product development and commercialization.

• Reelection of directors Alan Will and Trevor Moody was proposed and supported by the board.

• Appointed Pharoah Garma as Chief Regulatory Officer in December 2024.

• Expanded commercial leadership team with a new Chief Commercial Officer, two VPs of Sales, and a VP of Marketing.